Nonnucleoside reverse transcriptase inhibitor marketed for AIDS therapy.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D017277:Drug Approval; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors*; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D054303:HIV Reverse Transcriptase